🚀 VC round data is live in beta, check it out!
Darwin Valuation Multiples
Discover revenue and EBITDA valuation multiples for Darwin and similar public comparables like Clover Corp, Cibus, ArcticZymes, Amoeba and more.
Darwin Overview
About Darwin
Darwin AG is a biotechnology company. It is engaged in the field of human genetics. The group also develops and sells personalized dietary supplements and cosmetics. Its brand includes Novodaily; Rootine and Genopedia.
Founded
2021
HQ
Employees
N/A
Website
Financials (LTM)
EV
$29M
Darwin Financials
Darwin reported last 12-month revenue of $70M and negative EBITDA of ($1M).
In the same LTM period, Darwin generated $25M in gross profit, ($1M) in EBITDA losses, and $3M in net income.
Revenue (LTM)
Darwin P&L
In the most recent fiscal year, Darwin reported revenue of $30M and EBITDA of $43M.
Darwin expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $70M | XXX | $30M | XXX | XXX | XXX |
| Gross Profit | $25M | XXX | $15M | XXX | XXX | XXX |
| Gross Margin | 35% | XXX | 49% | XXX | XXX | XXX |
| EBITDA | ($1M) | XXX | $43M | XXX | XXX | XXX |
| EBITDA Margin | (2%) | XXX | 146% | XXX | XXX | XXX |
| EBIT Margin | (6%) | XXX | 104% | XXX | XXX | XXX |
| Net Profit | $3M | XXX | $22M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 73% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Darwin Stock Performance
Darwin has current market cap of $118M, and enterprise value of $29M.
Market Cap Evolution
Darwin's stock price is $9.84.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $29M | $118M | -0.2% | XXX | XXX | XXX | $1.81 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDarwin Valuation Multiples
Darwin trades at 0.4x EV/Revenue multiple, and (23.8x) EV/EBITDA.
EV / Revenue (LTM)
Darwin Financial Valuation Multiples
As of April 19, 2026, Darwin has market cap of $118M and EV of $29M.
Equity research analysts estimate Darwin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Darwin has a P/E ratio of 39.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $118M | XXX | $118M | XXX | XXX | XXX |
| EV (current) | $29M | XXX | $29M | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | (23.8x) | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBIT | (6.6x) | XXX | 0.9x | XXX | XXX | XXX |
| EV/Gross Profit | 1.2x | XXX | 2.0x | XXX | XXX | XXX |
| P/E | 39.8x | XXX | 5.4x | XXX | XXX | XXX |
| EV/FCF | (1.6x) | XXX | (0.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Darwin Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Darwin Margins & Growth Rates
Darwin's revenue in the last 12 month grew by 38%.
Darwin's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Darwin's rule of X is 75% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Darwin Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 38% | XXX | 118% | XXX | XXX | XXX |
| EBITDA Margin | (2%) | XXX | 146% | XXX | XXX | XXX |
| EBITDA Growth | (789%) | XXX | (108%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 33% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 75% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | (55%) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Darwin Public Comps
See public comps and valuation multiples for other Bioindustrials comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Darwin | XXX | XXX | XXX | XXX | XXX | XXX |
| Clover Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Cibus | XXX | XXX | XXX | XXX | XXX | XXX |
| ArcticZymes | XXX | XXX | XXX | XXX | XXX | XXX |
| Amoeba | XXX | XXX | XXX | XXX | XXX | XXX |
| American Vanguard | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Darwin M&A Activity
Darwin acquired XXX companies to date.
Last acquisition by Darwin was on XXXXXXXX, XXXXX. Darwin acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Darwin
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDarwin Investment Activity
Darwin invested in XXX companies to date.
Darwin made its latest investment on XXXXXXXX, XXXXX. Darwin invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Darwin
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Darwin
| When was Darwin founded? | Darwin was founded in 2021. |
| Where is Darwin headquartered? | Darwin is headquartered in Germany. |
| Is Darwin publicly listed? | Yes, Darwin is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Darwin? | Darwin trades under 7V0 ticker. |
| When did Darwin go public? | Darwin went public in 2023. |
| Who are competitors of Darwin? | Darwin main competitors are Clover Corp, Cibus, ArcticZymes, Amoeba. |
| What is the current market cap of Darwin? | Darwin's current market cap is $118M. |
| What is the current revenue of Darwin? | Darwin's last 12 months revenue is $70M. |
| What is the current revenue growth of Darwin? | Darwin revenue growth (NTM/LTM) is 38%. |
| What is the current EV/Revenue multiple of Darwin? | Current revenue multiple of Darwin is 0.4x. |
| Is Darwin profitable? | No, Darwin is not profitable. |
| What is the current EBITDA of Darwin? | Darwin has negative EBITDA and is not profitable. |
| What is Darwin's EBITDA margin? | Darwin's last 12 months EBITDA margin is (2%). |
| What is the current EV/EBITDA multiple of Darwin? | Current EBITDA multiple of Darwin is (23.8x). |
| What is the current FCF of Darwin? | Darwin's last 12 months FCF is ($19M). |
| What is Darwin's FCF margin? | Darwin's last 12 months FCF margin is (27%). |
| What is the current EV/FCF multiple of Darwin? | Current FCF multiple of Darwin is (1.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.